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RAD51-dependent recruitment of TERRA 
lncRNA to telomeres through R-loops
Marianna Feretzaki1, Michaela Pospisilova2, Rita Valador Fernandes1, Thomas Lunardi1,  
Lumir Krejci2,3 ✉ & Joachim Lingner1 ✉
Telomeres—repeated, noncoding nucleotide motifs and associated proteins that are 
found at the ends of eukaryotic chromosomes—mediate genome stability and 
determine cellular lifespan1. Telomeric-repeat-containing RNA (TERRA) is a class of 
long noncoding RNAs (lncRNAs) that are transcribed from chromosome ends2,3; these 
RNAs in turn regulate telomeric chromatin structure and telomere maintenance 
through the telomere-extending enzyme telomerase4–6 and homology-directed DNA 
repair7,8. The mechanisms by which TERRA is recruited to chromosome ends remain 
poorly defined. Here we develop a reporter system with which to dissect the underlying 
mechanisms, and show that the UUAGGG repeats of TERRA are both necessary and 
sufficient to target TERRA to chromosome ends. TERRA preferentially associates with 
short telomeres through the formation of telomeric DNA–RNA hybrid (R-loop) 
structures that can form in trans. Telomere association and R-loop formation trigger 
telomere fragility and are promoted by the recombinase RAD51 and its interacting 
partner BRCA2, but counteracted by the RNA-surveillance factors RNaseH1 and TRF1. 
RAD51 physically interacts with TERRA and catalyses R-loop formation with TERRA 
in vitro, suggesting a direct involvement of this DNA recombinase in the recruitment of 
TERRA by strand invasion. Together, our findings reveal a RAD51-dependent pathway 
that governs TERRA-mediated R-loop formation after transcription, providing a 
mechanism for the recruitment of lncRNAs to new loci in trans.
TERRA is transcribed from numerous chromosome ends, and comprises 
both subtelomeric sequences and telomeric repeats. More than 50% 
of TERRA is associated with chromatin9. To investigate how TERRA is 
recruited to or retained at telomeres, we generated a plasmid encoding 
24 copies of the stem-loop of phage PP7 (ref. 10) under the control of the 
tetracycline-inducible (TET) promoter, followed by 90 TTAGGG repeats 
(Fig. 1a). To generate full-length TERRA transcripts, we also cloned the 
human chromosome Xq and 15q subtelomeric regions containing the 
TERRA start sites between the PP7 stem-loops and the TTAGGG repeats. 
The constructs were then transiently transfected into HeLa clones 
that were constitutively expressing the PP7 coat protein fused to GFP 
(PCP–GFP) and a nuclear-localization signal. PCP–GFP exhibited a 
diffuse signal in the nucleus but formed nuclear foci upon expression 
of the PP7 stem-loops, which are bound by PCP and can gather up to 
48 PCP–GFP molecules per RNA. These foci did not co-localize with 
telomeres (Fig. 1b). The fusion of the subtelomeric region of 15q or 
Xq TERRA to the stem-loops did not promote substantial trafficking 
of the PP7 foci to telomeres. However, when the telomeric TTAGGG 
repeats were fused downstream of PP7, co-localization with telomeres 
occurred, as analysed by conventional and confocal imaging (Fig. 1b), 
indicating that the 5′-UUAGGG-3′ repeats of TERRA drive telomere asso-
ciation. The full-length PP7-tagged 15q and Xq chimaeric TERRA also 
showed marked co-localization with telomeres (Fig. 1b and Extended 
Data Fig. 1a). Therefore, chimaeric TERRAs that originated from a plas-
mid were directed to telomeres in trans.
To eliminate possible confounding effects due to the high plasmid 
copy number or increased levels of transgenic TERRA, we used CRISPR–
Cas9 technology to integrate the chimaeric TERRA constructs into 
the genome at the adeno-associated-virus integration site 1 (AAVS1) 
on chromosome 19, which represents a safe harbour for transgene 
expression11 (Extended Data Fig. 1b). Following isolation of clones, we 
confirmed monoallelic site-specific integration of the full constructs 
by polymerase chain reaction (PCR) and sequencing. These TERRA 
expression levels were lower than the levels of expression from plas-
mids, giving one to three foci—indicative of displacement from the 
transcription site. But, similar to the results obtained upon transient 
transfection, the PP7 loops formed nuclear foci, and only when fused 
to 5′-UUAGGG-3′ repeats did the chimaeric RNAs co-localize with tel-
omeres (Extended Data Fig. 1c, d).
Shorter telomeres recruit more TERRA
In Saccharomyces cerevisiae and Schizosaccharomyces pombe, short 
telomeres recruit more TERRA, possibly to facilitate telomere main-
tenance through recombination or telomerase recruitment5,6,8. To 
explore the putative roles of telomere length in TERRA recruitment 
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in human cells, we isolated individual HeLa clones that constitutively 
expressed the PCP–GFP and measured telomere lengths by telomere 
restriction fragment length (TRF) analysis (Extended Data Fig. 2). Cells 
carrying short telomeres recruited TERRA much more efficiently than 
cells with long telomeres, as seen upon transient or stable expression 

































































































24 h 24 h 24 h








































































































































































































































Short telomeres (3 kb)
5 μm 5 μm 5 μm
Fig. 1 | Transgenic TERRA associates with telomeres in a manner that depends 
on RAD51. a, Chimaeric TERRA construct (top) and assay for TERRA localization 
(bottom). Using lipofectamine, plasmids were transfected into HeLa cells 
constitutively expressing PCP–GFP protein. After 24 h, transcription of TERRA 
was induced with doxycycline. Chimaeric TERRA, which is recognized and bound 
by PCP–GFP, was analysed 24 h after induction. CMV, cytomegalovirus.  
b, Fluorescence in situ hybridization (FISH) analysis of telomeric DNA (red) and 
immunofluorescence of GFP (green) were used to assess the co-localization of 
transiently expressed PP7 constructs with telomeres. Confocal images are 
shown. White arrows indicate co-localization of PP7 foci with telomeric signals.  
c, To identify proteins involved in the localization of TERRA at telomeres, we used 
siRNAs to target factors implicated in TERRA and telomere biology. HeLa clones 
with long (10-kilobase average) and short (3 kb) telomeres were transfected first 
with siRNA pools and then with chimaeric TERRA. The percentage of 
co-localizing TERRA foci was assessed by telomeric FISH combined with GFP 
immunofluorescence. n = 2 biologically independent experiments; more than 40 
nuclei were analysed per condition; data are means ± s.d. One-way analysis of 
variance (ANOVA) with Dunnett’s multiple comparisons test was used, 
comparing all conditions with control siRNA (siControl): *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001. d, The enzymatic activity of RAD51 is required to 
recruit TERRA. Endogenous RAD51 was depleted with siRNA, and wild-type 
RAD51 or the RAD51 II3A mutant was expressed from plasmid containing 
complementary DNA. The co-localization of TERRA with telomeres was assessed 
as in c. n = 3 biologically independent experiments; more than 80 nuclei were 
analysed per condition; data are means ± s.d. A two-tailed unpaired t-test was 
used to calculate P-values: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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more accessible to recruitment or retention of TERRA; alternatively, 
long telomeres might contain active systems that expel TERRA. In both 
experiments the overall expression levels of chimaeric TERRA varied in 
individual clones, but this did not correlate with telomere length and 
telomere recruitment of TERRA (Extended Data Fig. 2b, d).
Recombination factors enable TERRA recruitment
To identify proteins involved in the localization of TERRA at telomeres, 
we performed screens using short interfering RNAs (siRNAs) to target 
selected factors implicated in TERRA and telomere biology. Using cell 
lines with long or short telomeres, we transfected first siRNA pools and 
then the 15q TERRA construct. After inducing TERRA expression with 
doxycycline, we analysed the cells (Fig. 1c) and evaluated the level of 
depletion of each factor by using reverse transcription with quantita-
tive PCR (RT–qPCR) or western blotting (Extended Data Fig. 3a, b). We 
found that the number of transgenic TERRA foci was not affected by 
individual depletions, and we observed no striking effects on levels 
of selected endogenous TERRA molecules (Extended Data Fig. 3c, d). 
Among tested factors, depletion of telomeric repeat factor 1 (TRF1) 
significantly increased TERRA co-localization at short and long tel-
omeres, while removal of TRF2 led to a milder increase in recruitment 
(Fig. 1c). Depletion of the nonsense-mediated decay (NMD) factors 
also stimulated co-localization of TERRA at long telomeres, support-
ing their crucial role in displacing TERRA from chromosome ends2. 
Similarly, removal of RNaseH1 resulted in a substantial accumulation 
of TERRA at chromosome ends in cells with long telomeres (Fig. 1c). 
This result indicated that TERRA recruitment to, or retention at, long 
telomeres involves the formation of DNA–RNA hybrids. In cells with 
short telomeres, depletion of RNaseH1 only marginally increased the 
co-localization of TERRA with telomeres. The roles of NMD factors 
in cells with short telomeres could not be analysed, as their deple-
tion caused cell death. Notably, depletion of RAD51—which facilitates 
strand invasion of DNA molecules during homology-directed repair 
(HDR)—led to a substantial decrease in TERRA recruitment to both 
long and short telomeres (Fig. 1c, d).
The involvement of RAD51 in TERRA recruitment prompted us 
to interrogate the role of the BRCA2 protein in TERRA trafficking. 
BRCA2 loads RAD51 and promotes the displacement of replication 
protein A (RPA), allowing the formation of stable filaments of RAD51 on 
single-stranded DNA (ssDNA) that are capable of homology search to 
facilitate HDR during double-strand-break repair; BRCA2 also protects 
stalled replication forks12,13. We found that depletion of BRCA2 led to 
a marginal decrease in TERRA recruitment at long, but more promi-
nent reduction at short, telomeres (Extended Data Fig. 4a). However, 
removal of BRCA2 also diminished total RAD51 protein levels in both 
cell lines (Extended Data Fig. 4a). Finally, we tested whether RAD51 
enzymatic activity is required for TERRA recruitment, taking advan-
tage of a mutation (RAD51 II3A) that allows the protein to retain its 
DNA-binding but not its strand-invasion activity14. In siRAD51-treated 
cells, the expression of wild-type RAD51 from complementary DNA 
largely rescued TERRA co-localization with telomeres, but expression 
of RAD51 II3A did not (Fig. 1d and Extended Data Fig. 4b). Therefore, 
the enzymatic activity of RAD51 is required for TERRA to associate 
with telomeres. Overall, these data suggest that the HDR machinery 
promotes the recruitment of TERRA to telomeres.
TERRA forms R-loops causing telomere fragility
As the association of TERRA with long telomeres was increased upon 
depletion of RNaseH1, we hypothesized that the transgenic TERRA may 
form R-loops with telomeres in trans. To explore this possibility, we 
applied the DNA–RNA immunoprecipitation protocol (DRIP), in which 
the specificity of the S9.6 monoclonal antibody for eight to nine base 
pairs of DNA–RNA hybrids is exploited15. Precipitated nucleic acids 
were probed for telomeric repeats, and, as a control for specificity, 
isolated nucleic acids were treated in vitro with RNaseH1 before immu-
noprecipitation. Abolishment of the signal upon pretreatment with 
RNaseH1 confirmed the specificity of the assay for telomeric R-loops 
(Fig. 2a). As expected, we detected R-loops at telomeres in wild-type 
cells (Fig. 2a). Depletion of RNaseH1 led to an increase in the number of 
R-loops, while its overexpression to a decrease in R-loops at both long 
and short telomeres (Fig. 2a and Extended Data Fig. 5a). Overexpres-
sion of chimaeric TERRA further increased the frequency of R-loops 
in cells with both long and short telomeres (Fig. 2a); this frequency 
again increased upon depletion of RNaseH1 and decreased upon its 
overexpression (Fig. 2a and Extended Data Fig. 5a), indicating that the 
transgenic TERRA formed DNA–RNA hybrids.
The DRIP assay (Fig. 2a) could not distinguish to what extent the DRIP 
signals for transgenic TERRA were derived from R-loops forming within 
the transgenic plasmid during transcription, or R-loops forming after 
transcription in trans with telomeres. To measure R-loops specifically 
at telomeres, we used the DRIP samples derived from HeLa cells with 
long telomeres (Fig. 2a), and determined the presence of four spe-
cific chromosome ends by qPCR using subtelomere-specific primers 
residing in immediate proximity to the terminal 5′-TTAGGG-3′ repeats 
(Fig. 2b). Telomeric R-loops became detectable at the ends of all four 
chromosomes upon depletion of RNaseH1 (Fig. 2b). Specifically, 1q, 
10q and 13q subtelomeric DNA increased strongly in abundance upon 
expression of transgenic PP7–15qTERRA, indicating that R-loops had 
formed at these telomeres with PP7–15qTERRA. The 15q subtelomeric 
signal was enhanced even more extensively, presumably because of 
R-loops forming with plasmid DNA containing the 15q sequence. As 
with wild-type TERRA, overexpression of RNaseH1 almost completely 
abolished the signals, whereas RNaseH1 depletion increased R-loop 
abundance. We sequenced the qPCR products (Extended Data Fig. 5b), 
verifying the identity of products for each chromosome end. Together, 
these data confirmed that transgenic PP7–15qTERRA associated with 
telomeres in trans through the formation of R-loop structures.
TERRA R-loops have been implicated in interfering with telomere 
replication7,16–18; this is manifested in telomere fragility19, characterized 
by the accumulation of telomeric signals in metaphase chromosomes 
with a smeary or discontinuous appearance (Extended Data Fig. 6a). 
We found that transgenic TERRA increased telomere fragility (Fig. 2c 
and Extended Data Fig. 6b), which was suppressed by depletion of 
RAD51 or overexpression of RNaseH1 but increased by depletion of 
RNaseH1 (Fig. 2d and Extended Data Fig. 6c, d). These results confirm 
that, after transcription from plasmids, TERRA forms R-loops at tel-
omeres in trans.
RAD51 promotes telomeric R-loop formation
We next used the DRIP assay to test the role of RAD51 in the formation 
of hybrids containing endogenous TERRA at telomeres in wild-type cell 
lines (Fig. 2e and Extended Data Fig. 7a). While depletion of RNaseH1 led 
to the expected mild increase in R-loops, depletion of RAD51 caused a 
substantial decrease in hybrid accumulation. Even stronger reduction 
of R-loops was observed in RAD51-depleted cells with short telom-
eres, which are characterized by higher levels of DNA–RNA hybrids. 
Therefore, RAD51 promotes the association of endogenous TERRA 
with telomeres through R-loop formation.
We hypothesized either that RAD51 binds TERRA to catalyse its strand 
invasion into the telomeric repeats (Extended Data Fig. 7b, lower panel), 
or that TERRA might hybridize to exposed single-stranded telomeric 
DNA during RAD51-mediated HDR between telomeric DNA molecules, 
even in the absence of a physical interaction between TERRA with RAD51 
(Extended Data Fig. 7b, upper panel). To explore these hypotheses, we 
performed native RNA immunoprecipitations using anti-RAD51 anti-
bodies in HeLa cells. As a control, we also included antibodies specific 
for hnRNPA1, as this protein binds TERRA4. Immunoprecipitation of 
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endogenous RAD51 specifically retrieved TERRA and not the nuclear 
U1 small nuclear RNA (snRNA; Fig. 3a and Extended Data Fig. 7c), and 
similar results were observed in the U2OS ALT cell line (Extended Data 
Fig. 7d). The TERRA signal was sensitive to treatment with RNaseA, 
showing a specific recovery of RNA, but the RNA signal was insensitive 
to treatment with DNaseI. Together these results indicate that TERRA 
associates with RAD51 in vivo.
We wished to determine whether purified RAD51 can bind TERRA 
directly by carrying out electrophoretic mobility shift assays (EMSAs). 
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Fig. 2 | TERRA forms R-loops in trans, inducing telomere fragility in a 
RAD51-dependent way. a, Left panels, detection of telomeric hybrids on 
dot-blots. Telomeric hybrids were isolated from cells with long or short telomeres 
by DRIP using the S9.6 antibody. Cells expressed either the PP7 stem-loops or the 
PP7–15qTERRA, and had been transfected with control siRNA (siC), siRNAs against 
RNaseH1 (RNH1), or an RNH1-overexpressing plasmid. In vitro treatment with 
RNH1 served as a negative control. Right panels, quantification of signals. b, Left, 
schematic representation showing the expression of PP7–15qTERRA from a 
plasmid, forming R-loops in trans at telomeres 1q, 10q and 13q. Right, telomeric 
hybrids arising at the indicated chromosome ends were quantified by qPCR using 
primers that amplify specific subtelomeric DNA found next to the telomeric tracts 
in cells with long telomeres. c, Telomere fragility induced upon expression of 
TERRA from a plasmid. The fraction of fragile telomeres was quantified on 
metaphase chromosomes stained with a telomeric FISH probe (Extended Data 
Fig. 6). d, Effects of RNH1 and RAD51 on telomere fragility. In cells expressing PP7-
15qTERRA from a plasmid, telomere fragility was quantified upon depletion or 
overexpression of RNH1, or depletion of RAD51. e, Detection of endogenous 
telomeric R-loops in cells transfected with siC, siRNH1 or siRAD51. For all panels, 
n = 3 biologically independent experiments; data are means ± s.d. Two-tailed 
unpaired t-tests were used to calculate P-values: *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001. For c, d, the numbers of metaphases scored are indicated for each 
condition in Extended Data Fig. 6b, c.
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or telomeric DNA oligonucleotides, and resolved the reactions by 
agarose-gel electrophoresis (Fig. 3b). RAD51 bound the TERRA oli-
gonucleotide with threefold higher affinity than the corresponding 
telomeric DNA sequence (TelDNA), as with TERRA oligonucleotide a 
lower protein concentration was required to obtain shifted oligonucleo-
tide–RAD51 complexes (Fig. 3b). The binding of RAD51 to the TERRA 
oligonucleotide was tighter than to an unrelated RNA (Extended Data 
Fig. 7e) and also more stable when compared with telomeric DNA, as 
shown by a stability assay in which pre-formed TERRA–RAD51 or Tel-
DNA–RAD51 complexes were challenged with an excess of unlabelled 
49-mer competitor ssDNA (cDNA) (Extended Data Fig. 7f).
To test whether RAD51 promotes R-loop formation in vitro, we carried 
out a strand-invasion assay using recombinant RAD51 and telomeric 
RNA and DNA (Fig. 3c–e). Wild-type RAD51, unlike the catalytically 
dead RAD51 II3A, catalysed both R-loop and D-loop formation in a 
concentration-dependent manner (Extended Data Fig. 8a). As expected, 
canonical R-loops were sensitive to treatment with RNaseH1 and were 
supershifted with the R-loop recognizing S9.6 antibody when combined 
with anti-mouse IgG (Extended Data Fig. 8b, c). Together, these data 
support a direct role of the RAD51 protein in localizing TERRA to initi-
ate strand invasion and promote the formation of DNA–RNA hybrids 
at telomeres.
Discussion
Our data reveal the mechanism by which TERRA is recruited to chro-
mosome ends through RNA strand invasion. The recruitment of 
TERRA and formation of R-loops depend on the recombinase RAD51 
and the 5′-UUAGGG-3′ repeats of TERRA. Although the subtelomeric 
TERRA sequences were not required for telomere recruitment in our 
assay, we do not exclude the possibility that they may contribute 
by targeting endogenous TERRA molecules to their native chromo-
some ends. The observed base pairing between TERRA and telom-
eric DNA provides a mechanism for how this long noncoding RNA 
can encounter its major site of action at chromosome ends. There-
fore, the recruitment of TERRA seems to occur through a process 
that strongly resembles the strand-invasion and homology-search 
mechanism exploited in all living organisms during DNA repair by 
HDR, and which is also characteristic of telomere stabilization by the 
‘alternative lengthening of telomeres’ (ALT) mechanism in cancer 
cells. A direct involvement of RAD51 in the strand-invasion reaction 
is supported by our finding that RAD51 strongly binds TERRA and 
catalyses strand invasion into telomeric sequences in vitro. However, 
it is likely that there are important differences between DNA- and 
RNA-mediated strand invasion with the regard to the mechanism 
and the requirement for accessory factors, which must be explored 
in the future.
The increased formation of R-loops and association of RAD51 with 
short telomeres has previously been shown in yeast8. Our findings in 
human cells are consistent with these observations. Furthermore, we 
reveal that TERRA can form R-loops post-transcriptionally at telomeres 
in trans. R-loops have generally been assumed to form only during 
transcription, through the unsuccessful removal of native RNA from 
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Fig. 3 | RAD51 associates with TERRA and catalyses R-loop formation. a, Native 
RNA-immunoprecipitation assays using anti-RAD51 and anti-hnRNPA1 antibodies 
were performed in extracts from HeLa cell clones with long or short telomeres. 
Western blotting was used to evaluate the efficiency of immunoprecipitation of 
RAD51 and hnRNPA1 (and the co-immunoprecipitation of BRCA2; Extended Data 
Fig. 7c, d). Immunoprecipitation-recovered RNA was analysed for TERRA and U1 
snRNA. n = 3 biologically independent experiments; data are means ± s.d. b, The 
affinity of RAD51 for TERRA and telomeric DNA (TelDNA) oligonucleotides was 
analysed by electrophoretic mobility shift assay (EMSA). Fluorescently labelled 
(pink star) RNA or DNA substrates (20 nM) were incubated with increasing 
concentrations of RAD51 protein (0 nM, 550 nM, 1,100 nM, 2,200 nM and 
4,400 nM). Quantification is shown at the bottom. n = 3 independent 
experiments; data are means ± s.d. c, Assay for the formation of R-loops and 
D-loops. d, The formation of R-loops depends on the concentration of RAD51: 
detection on native gel (left) and quantification (right). n = 3 independent 
experiments; data are means ± s.d. e, Detection of D-loops on native gel (left) and 
quantification (right). n = 3 independent experiments; data are means ± s.d.
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R-loops may also form at loci that are distinct from the site of synthesis 
of the RNA21. Our work here suggests that R-loop formation in trans 
plays a major part in telomere homeostasis. Through its mechanism of 
recruitment, TERRA may represent a scaffold that guides and regulates 
telomerase, HDR proteins and chromatin modifiers specifically at the 
chromosome ends that may need their attention. It will be interesting 
to see which other lncRNAs are recruited to their sites of action through 
similar mechanisms.
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Methods
No statistical methods were used to predetermine sample size. The 
experiments were not randomized and investigators were not blinded 
to allocation during experiments and outcome assessment.
Cell culture and transfections
The telomerase-positive cell line HeLa (cervical cancer) was from 
the American Type Culture Collection (ATCC), and the ALT cell line 
U2OS (osteosarcoma) from the European Collection of Authenticated 
Cell Cultures (ECACC). The cells were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS) and 100 U ml−1 of penicillin/streptomycin (Thermo 
Fisher Scientific). The cell lines were maintained in a 5% CO2 incuba-
tor at 37 °C and were routinely checked to ensure that they remained 
mycoplasma-free.
HeLa cells were transfected with lipofectamine 2000 according to 
the manufacturer’s instructions (Invitrogen). To induce TERRA tran-
scription, doxycycline (1 μg ml−1) was added to the medium 24 h after 
transfection, and the cells were harvested 48 h after transfection. To 
isolate clones containing integrated TERRA transgenes, puromycin 
(1 μg ml−1) was added to the medium 24 h following transfection using 
the pSpCas9(BB)-2A-Puro plasmid. Selection was maintained for 5 days. 
SiRNAs were purchased as pools from Dharmacon (siGENOME SMART-
pool; Extended Data Table 1). Cells were transfected with 20 pmol siR-
NAs using calcium phosphate transfection in 6-well plates in DMEM 
supplemented with 10% FBS. Cells were harvested 72 h after transfec-
tion. Wild-type RAD51 or the RAD51 II3A mutant was expressed from 
plasmid containing complementary DNA14.
Lentivirus production and cell transduction
Plasmids pMD2.G (1 μg) and pCMVR8.74 (3 μg) (gifts from D. Trono, 
EPFL) were mixed with PP7_eGFP (3 μg) (a gift from D. Larson, National 
Institutes of Health (NIH)) or pLenti CMV rtTA3 Hygro (Addgene cata-
logue number 26730) for transfection of HEK293T cells in Optimem 
medium (Thermo Fisher Scientific) using lipofectamine 2000. The 
transfection mix was incubated overnight and the medium replaced 
the next day. Supernatants were collected on the next two consecutive 
days upon centrifugation, and cleared through a 0.22-μm filter unit 
(Stericup, Millipore), before the viruses were aliquoted and frozen 
at −80 °C. HeLa cells were transduced with 1 ml of viral particles of 
pLenti CMV rtTA3 Hygro. Following infection, the cells were selected 
with hygromycin (200 μg ml−1) for 5 days, before they were infected 
again with the PP7–GFP viruses. GFP-positive clones with similar GFP 
intensity were isolated with a FACSAria Fusion sorter by EPFL’s flow 
cytometry core facility.
Cloning of TERRA constructs
TERRA constructs were cloned in the pTRE2puro vector of Clontech’s 
TET-ON system without the corresponding polyA region. The PP7 
stem-loops were amplified from Addgene plasmid #61762 (a gift from 
D. Larson) and introduced into pTRE2puro through in-fusion cloning. 
To amplify the TTAGGG sequence, we performed PCR using the Phu-
sion Green Hot Start II high-fidelity DNA polymerase (F537S) with no 
template in a reaction containing: 1× GC Phusion buffer, 0.2 mM dNTPs, 
0.4 μM primer 5′-TTAGGGTTAGGGTTAGGGTTAGGGTTAGGG-3′, 0.4 μM 
primer 5′- CCCTAACCCTAACCCTAACCCTAACCCTAA-3′, and 2 U of 
polymerase. The PCR consisted of 30 s at 98 °C followed by 10 cycles at 
98 °C for 5 s, 60 °C for 10 s, and 72 °C for 15 s. DNA products of variable 
size were fractionated on a 1.2% agarose gel, and the desired size was 
excised, extracted with a QIAquick gel extraction kit, and cloned into 
the pTRE2puro vector containing the 24 copies of PP7 stem-loops. Sub-
telomeric sequences were amplified using a high-fidelity polymerase 
from phenol–chloroform-extracted genomic DNA from HeLa cells, and 
introduced into the corresponding vectors through in-fusion cloning. 
All constructs were verified by restriction digestion and sequencing. 
The plasmids were amplified in a homologous-recombination-deficient 
E. coli strain (Stbl3) at 30 °C. All of the primers are listed in Extended 
Data Table 1.
Generation of integrated TERRA cell lines
The integration of TERRA constructs into the AAVS1 locus was per-
formed as described22. The guide RNA for AAVS1 (5′-ACCCCACAG 
TGGGGCCACTA-3′) and its complementary strand were annealed, and 
cloned into the pSpCas9(BB)-2A-Puro plasmid acquired from Addgene 
(catalogue number 48139). The donor template encompassed roughly 
800 base pairs of homology arms for AAVS1, which were amplified from 
HeLa genomic DNA, and cloned into the plasmids containing the control 
PP7 stem-loop construct and the different TERRA transgenes. HeLa 
cells were transfected with both the gRNA/Cas9 and donor template 
vectors. Individual clones were screened by PCR for the presence of 
the transgene in the AAVS1 locus.
Immunofluorescence and FISH
Cells were grown on glass coverslips by following the culture conditions 
above. The coverslips were washed twice with 1× phosphate-buffered 
saline (PBS), fixed with 4% paraformaldehyde for 10 min at room tem-
perature, and washed twice with 1× PBS. The cells were then permea-
bilized in 1× detergent solution for 5 min (0.1% Triton X-100, 0.02% 
SDS in 1× PBS), followed by pre-blocking with 2% bovine serum albu-
min (BSA) in 1× PBS for 10 min. Next the cells were blocked with 10% 
normal goat serum in 2%BSA/1× PBS for 30 min at room temperature. 
Coverslips were incubated with primary and then secondary antibod-
ies in blocking solution for 90 min each time at room temperature, 
and fixed with 4% paraformaldehyde for 5 min at room temperature; 
the samples were then dehydrated with increasing concentrations 
of ethanol. For FISH staining, the cells were incubated with hybridi-
zation solution containing 10 mM Tris–HCl pH 7.4, 70% formamide, 
0.5% blocking reagent and 1/1,000 Cy3 probe, denatured at 80 °C 
for 3 min, and hybridized for 3 h at room temperature. The cells were 
washed with wash 1 (10 mM Tris–HCl pH 7.4, 70% formamide) and wash 
2 (0.1 M Tris–HCl pH 7.4, 0.15 M NaCl, 0.08% Tween-20) twice, stained 
with 4′,6-diamidino-2-phenylindole (DAPI), and dehydrated with etha-
nol. Images were acquired on an Upright Zeiss Axioplan or on a Zeiss 
LSM700 equipped with an AxioCam MRm B/W. Images were processed 
and analysed with ImageJ and Adobe Photoshop. All statistical analy-
sis was performed using GraphPad Prism. All figures were created in 
Adobe Illustrator.
Telomeric FISH on metaphase spreads
Cells were treated with 0.05 μg ml−1 demecolcine for 2 h, collected and 
incubated in hypotonic solution (0.075 M KCl) at 37 °C for 8 min. Swol-
len cells were collected and fixed in ice-cold methanol:acetic acid (3:1) 
overnight at 4 °C. The next day, 100 μl of cell suspension was dropped 
onto slides, incubated at 70 °C for 1 min and air-dried overnight at room 
temperature. FISH staining was performed as above.
Telomere length analysis
HeLa genomic DNA was isolated with the Wizard genomic DNA puri-
fication kit according to the manufacturer’s instructions (Promega). 
Then, 6 μg of genomic DNA was digested with 30 U of HinfI and RsaI 
overnight at 37 °C. The digested DNA was mixed with 6× MassRuler 
DNA-loading dye (Thermo Fisher Scientific), loaded on a 0.8% agarose 
gel in 1× Tris–borate–EDTA (TBE) buffer, and fractionated by gel elec-
trophoresis at 2 V cm−1 for 20 h. The gels were dried for two hours at 
50 °C in vacuum, treated with denaturation buffer (0.5 M NaOH, 1.5 M 
NaCl) and neutralization buffer (0.5 M Tris-HCl pH 7.5, 1.5 M NaCl), and 
then pre-hybridized with Church buffer for 1 h at 50 °C. The gels were 
hybridized overnight at 50 °C with a randomly labelled TeloC probe as 
described23. The gels were washed for 1 h at 50 °C with 4× saline sodium 
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citrate (SSC), 4× SSC 0.1% SDS, and 2× SSC 0.1%SDS, exposed to a phos-
phorimager screen and analysed on a Typhoon phosphorimager (GE).
RT–qPCR
For RT–qPCR of TERRA, 3 × 106 cells were harvested following trans-
fection of the chimaeric TERRA constructs. RNA was isolated with a 
NucleoSpin RNA kit (Macherey-Nagel). RT–qPCR for 15qTERRA was 
carried out using our previously described protocol24. To assess mes-
senger RNA levels following siRNA transfections, we used ThermoFisher 
Scientific’s SuperScript III reverse transcriptase and Power SYBR Green 
PCR master mix on an Applied Biosystems 7900HT fast real-time system 
according to the manufacturer’s instructions.
Western blotting
Antibodies are listed in Extended Data Table 2. Protein samples were 
mixed with 2× Laemmli buffer, boiled for 5 min at 95 °C, run on 4–15% 
SDS–PAGE precast gels (Mini-PROTEAN TGX Gels, BioRad), transferred 
to nitrocellulose blotting membranes (Amersham), blocked with 
blocking solution (3% BSA in 1× PBS, 0.1% Tween-20), and incubated 
overnight at 4 °C with the corresponding primary antibody. Mem-
branes were washed three times for 5 min each with 1× PBS plus Tween 
(PBST) buffer, and then incubated for 1 h at room temperature with 
horseradish-peroxidase-conjugated secondary antibodies (Promega) 
in blocking solution. Membranes were washed again three times for 
5 min with 1× PBST before revealing them with a chemiluminescence 
detection kit (Western bright electrochemiluminescence, Advansta) 
and analysing them on a Vilber Fusion FX imaging system.
DNA–RNA immunoprecipitation
Cells at roughly 40% confluence in 6-well plates were transfected first 
with siRNAs and then, the next day, with plasmids. The cells were har-
vested on ice 48 h later, counted on a CASY cell counter and washed 
with 1× PBS; samples were taken for DRIP and western blot analysis. For 
DRIP, 107 cells were dissolved in 175 μl of ice-cold RLN buffer (50 mM 
Tris-HCl pH 8.0, 140 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40, 1 mM dithi-
othreitol (DTT), and 100 U ml−1 RNasIN PLUS), incubated on ice for 
5 min, and centrifuged (300g, 2 min, 4 °C). The nuclei were lysed in 
500 μl RA1 buffer (NucleoSpin RNA, Macherey-Nagel) containing 5 μl of 
β-mercaptoethanol, and homogenized by passing them through a 20G 
× 11/2 syringe (0.9 mm × 40 mm). The nucleic-acid-containing extracts 
were mixed with 250 μl H2O and 750 μl phenol:chloroform:isoamyla
lcohol (25:24:1) in a Phase Lock Gel heavy (5PRIME) and centrifuged 
(13,000g, 5 min, room temperature). The upper aqueous phase was 
mixed with 750 μl of ice-cold isopropanol, with addition of NaCl to 
50 mM, then incubated on ice for 30 min; precipitated nucleic acids 
were collected by centrifugation at 10,000g for 30 min at 4 °C. The 
pellets were washed twice with 70% ice-cold ethanol, air-dried, dis-
solved in 130 μl of H2O, and sonicated on a Covaris system (10% duty 
factor, 200 cycles per burst, for 180 s, with an AFA intensifier) to obtain 
fragments of 100–500 bp. Next, 90 μg of sonicated nucleic acids were 
mixed with RNaseH1 or H2O in RNaseH1 buffer (20 mM HEPES-KOH 
pH 7.5, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT) and incubated at 37 °C 
for 90 min. The samples were diluted ten times in DIP-1 buffer (10 mM 
HEPES-KOH pH 7.5, 275 mM NaCl, 0.1% Na-deoxycholate, 0.1% SDS, 
1% Triton X-100) and pre-cleared with 80 μl of sepharose protein G 
beads for 1 h, on a rotating wheel, at 4 °C. One per cent of the nucleic 
acids were kept as input. Half of the samples (roughly 45 μg of nucleic 
acids) were incubated with 3 μg of S9.6 antibody or mouse IgG and 
40 μl of sepharose protein G beads on a rotating wheel at 4 °C over-
night. The next day the samples were washed for 5 min on a rotating 
wheel at 4 °C with DIP-2 (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM 
EDTA pH 8.0, 1% Triton X-100, 0.1% Na-deoxycholate), DIP-3 (50 mM 
HEPES-KOH pH 7.5, 500 mM NaCl, 1 mM EDTA pH 8.0, 1% Triton-X100, 
0.1% Na-deoxycholate), DIP-4 (10 mM Tris-HCl pH 8.0, 1 mM EDTA 
pH 8.0, 250 mM LiCl, 1% NP-40, 1% Na-deoxycholate), and TE buffer 
(10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0). The samples were digested 
at 65 °C overnight with 10 μg ml−1 RNase (DNase-free (Roche)) in a buffer 
containing 20 mM Tris-HCl pH 8.0, 1% SDS, 0.1 M NaHCO3, 0.5 mM EDTA 
pH 8.0. The DNA was isolated using the Qiagen PCR clean-up kit. The 
DNA was pipetted onto a positively charged nylon membrane (Amer-
sham Hybond N+) and telomeric DNA was detected with a telomeric 
probe as described25.
RNA immunoprecipitation
Cells were grown to roughly 70% confluence in 15-cm dishes, harvested 
on ice, counted on a CASY cell counter, washed with 1× PBS, and lysed in 
RNA-immunoprecipitation RLN buffer (50 mM Tris-HCl pH 8.0, 140 mM 
NaCl, 1.5 mM MgCl2, 0.5% NP-40, 1 mM DTT, 400 U ml
−1 RNasIN PLUS, and 
protease inhibitors (Complete, Roche)). The lysates were pre-cleared 
with Dynabeads plus protein G for 1 h on a rotating wheel at 4 °C, and 
incubated overnight with 6 μg of the corresponding antibody on a 
rotating wheel at 4 °C. Next 35 μl of Dynabeads protein G (ThermoFisher 
Scientific) that had been preblocked with transfer RNA were added to 
each mixture and incubated for 2 h on a rotating wheel at 4 °C; this was 
followed by five washes with RLN buffer supplemented with 6 mM EDTA 
pH 8.0. The RNA was eluted in 1% SDS, 5 mM EDTA pH 8.0, and 5 mM 
β-mercaptoethanol at 42 °C for 30 min, followed by 30 min at 65 °C. The 
RNA was purified using the RNA clean-up protocol of the NucleoSpin 
RNA kit (Macherey-Nagel). The RNA was denatured at 65 °C for 3 min 
and pipetted on a positively charged nylon membrane (Amersham 
Hybond N+). TERRA and U1 snRNA were detected with corresponding 
probes as described26.
EMSA
RAD51 protein was purified27 and diluted in dilution buffer 
(25 mM Tris-HCl (pH 7.5), 10% (v/v) glycerol, 0.5 mM EDTA, 50 mM 
KCl, 1  mM DTT and 0.01% NP40). Increasing concentrations of 
RAD51 were incubated with 20  nM Cy3-labelled 41mer TERRA 
(5′-UUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGGGUUAGG-3′), 
41mer TelDNA(5′-TTAGGGTTAGGGTTAGGGTTAGGGTTAGG 
GTTAGGGTTAGG-3′), 41mer non-TelRNA (5′- AGUAUAUAUGAGUAAACUU 
GGUCUGACAGUUACCAAUGCUU-3′) or 40mer non-TelDNA 
(5′-AAATTAACAAGTATAATAAGAA ATAGAAACAAGAAATAGA-3′) sub-
strate at 37 °C for 10 min in 10 μl of buffer D (50 mM Tris-HCl (pH 7.5), 
50 mM KCl, 1 mM MgCl2, 1 mM ATP). Reaction mixtures were then 
crosslinked with 0.01% glutaraldehyde for 10 min. Products were 
resolved using 0.8% TBE agarose gels supplemented with 10 mM KCl 
at 4 °C for 50 min (6.5 V cm−1). Gels were imaged on a FLA-9000 scan-
ner (Fujifilm) and quantified with Multi Gauge version 3.2 (Fujifilm).
Stability EMSA
Fluorescently labelled 41mer TERRA or 41mer TelDNA substrates 
(20 nM) were incubated with indicated concentrations of RAD51 
at 37 °C for 10 min in 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM 
MgCl2 and 1 mM ATP. To challenge assembled RAD51–ssDNA com-
plexes, increasing concentrations of unlabelled 49mer competitor 
ssDNA (5′-CCTGTTCAAACGCACATATTAAGCATTTC CTGTCATTG 
GCGGCTAATTC-3′) were added and incubated for another 10 min at 
37 °C. Products were crosslinked with 0.005% glutaraldehyde for a 
further 10 min and resolved using a 0.8% TBE agarose gel supplemented 
with 10 mM KCl at 4 °C for 50 min (6.5 V cm−1). Gels were imaged on a 
FLA-9000 scanner (Fujifilm) and quantified with Multi Gauge version 
3.2 (Fujifilm).
Assays for R-loop/D-loop formation
Fluorescently labelled 41mer TERRA or 41mer TelDNA (50 nM) were 
pre-incubated for 10 min at 37 °C with increasing concentrations of 
RAD51 in 50 mM Tris-HCl (pH 7.5), 1 mM MgCl2 supplemented with 1 mM 
CaCl2 and 1 mM adenylyl-imidodiphosphate (AMP–PNP). The reaction 
was started by adding 600 ng pCR4-TOPO vector containing the 15q 
subtelomeric sequence followed by 15 copies of TTAGGG repeats. The 
mixture was incubated for another 10 min at 37 °C and then stopped 
by adding SDS (0.1%) and proteinase K (0.1 mg ml−1); this was followed 
by 3-min incubations at 37 °C. Reaction mixtures were separated on 
0.8% agarose gel and analysed as described above for EMSA. For diges-
tion of R-loops by RNaseH, the mixtures were incubated for 1 min with 
phenylmethylsulfonyl fluoride (PMSF; 2 mM) and with EGTA (1.6 mM) at 
37 °C to inhibit proteinase K and chelate calcium ions, respectively. The 
products were digested with RNaseH1 (6.8 mU μl−1, Thermo Scientific) 
or RNaseH2 (6.8 mU μl−1, New England Biolabs) for 1 min at 37 °C and 
resolved as above. For antibody-specific supershift of R-loops, the prod-
ucts were formed as described above for RNaseH digestion (but without 
EGTA) and then incubated with S9.6 antibodies (0.02 μg μl−1) for 2 min at 
37 °C and/or anti-mouse horseradish-peroxidase-conjugated antibody.
RNaseH1 digestion of telomeric DNA–RNA hybrids
Fluorescently labelled TERRA or non-telomeric RNAs were mixed with 
their corresponding complementary ssDNA in annealing buffer (10 mM 
Tris pH 8.5, 50 mM NaCl, 1 mM EDTA). To form DNA–RNA hybrids, the 
mixture was heated for 5 min at 95 °C, and then gradually cooled to 
room temperature. The DNA–RNA hybrid (40 nM) was cleaved by 
RNaseH1 (6.8 mU μl−1) in the presence or absence of 1 mM CaCl2 for 
10 min at 37 °C in 50 mM Tris (pH 7.5), 1 mM MgCl2 and 1 mM AMP–PNP. 
The reaction was stopped by adding SDS/proteinase K, and then incu-
bated for 10 min at 37 °C. Reaction mixtures were loaded on 10% PAGE 
gel, separated by electrophoresis (90 V for 60 min at 4 °C), scanned 
using an Image Reader FLA-9000 scanner and quantified by MultiGauge 
version 3.2 software.
Supershift of DNA–RNA hybrid with S9.6 antibody
Fluorescently labelled TERRA and non-telomeric DNA–RNA hybrids 
(40 nM) were incubated with 0.015 μg μl−1 of S9.6 antibody for 10 min 
at 37 °C, then crosslinked with 0.01% glutaraldehyde for 10 min at 37 °C 
and resolved using 0.8% TBE agarose gel at 4 °C for 50 min (6.5 V cm−1). 
Gels were imaged on a FLA-9000 scanner (Fujifilm) and quantified with 
Multi Gauge version 3.2 (Fujifilm).
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
The data that support the findings of this study are available from the 
corresponding authors upon reasonable request. Source data are pro-
vided with this paper.
 
22. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protocols 8, 
2281–2308 (2013).
23. Grolimund, L. et al. A quantitative telomeric chromatin isolation protocol identifies 
different telomeric states. Nat. Commun. 4, 2848 (2013).
24. Feretzaki, M. & Lingner, J. A practical qPCR approach to detect TERRA, the elusive 
telomeric repeat-containing RNA. Methods 114, 39–45 (2017).
25. Porro, A. et al. Functional characterization of the TERRA transcriptome at damaged 
telomeres. Nat. Commun. 5, 5379 (2014).
26. Porro, A., Feuerhahn, S. & Lingner, J. TERRA-reinforced association of LSD1 with MRE11 
promotes processing of uncapped telomeres. Cell Rep. 6, 765–776 (2014).
27. Špírek, M. et al. Human RAD51 rapidly forms intrinsically dynamic nucleoprotein 
filaments modulated by nucleotide binding state. Nucleic Acids Res. 46, 3967–3980 
(2018).
Acknowledgements We thank D. Larson (NIH), D. Bishop (Univ. Chicago), V. Simanis (EPFL),  
P. Gönczy (EPFL) and D. Trono (EPFL) for providing material. We also thank the members of the 
BIOP core facility at EPFL, members of the Gönczy laboratory and M. Spirek for technical 
support and advice and J. Cibulka for recombinant mutant RAD51 protein. M.F. was supported 
by the European Union’s Horizon 2020 research and innovation programme under Marie 
Skłodowska-Curie grant agreement 702824. J.L.’s laboratory was supported by the Swiss 
National Science Foundation (SNFS grant 310030_184718), the SNFS-funded National Centres 
of Competence in Research (NCCR) RNA and disease network (grant 182880), and EPFL. L.K.’s 
laboratory was supported by the European Structural and Investment Funds, Operational 
Programme Research, Development and Education ‘Preclinical Progression of New Organic 
Compounds with Targeted Biological Activity’ (Preclinprogress) (CZ.02.1.01/0.0/0.0/16_025/00
07381); a Wellcome Trust Collaborative Grant 206292/E/17/Z; the Czech Science Foundation 
(GACR 17-17720S); and the National Program of Sustainability II (MEYS CR, project number 
LQ1605). Both J.L. and L.K. were also supported by the European Union's Horizon 2020 
research and innovation programme under grant agreement 812829.
Author contributions M.F. and J.L. conceived the study. M.F. and R.V.F. executed all cell and 
molecular biology experiments. M.P. performed all biochemistry experiments and T.L. some 
EMSA experiments. L.K. conceived the RAD51-based biochemistry experiments and advised 
on the text. J.L. and M.F. wrote the paper.
Competing interests The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41586-020-
2815-6.
Correspondence and requests for materials should be addressed to L.K. or J.L.
Peer review information Nature thanks the anonymous reviewers for their contribution to the 
peer review of this work.


























































































































































Extended Data Fig. 1 | Co-localization of transgenic TERRA with telomeres. 
a, Quantification of co-localization of transgenic RNA foci expressed from 
plasmids with telomeres. b, Strategy for targeting the AAVS1 locus through 
CRISPR–CAS9 to integrate chimaeric TERRA constructs into the genome. LHA 
and RHA, left and right homology arms. c, Quantification of co-localization of 
transgenic RNA foci with telomeres when TERRA was expressed from the 
AAVS1 locus. d, Confocal images obtained when TERRA was expressed from the 
AAVS1 locus. For a, c, n = 3 biologically independent experiments; data are 
mean ± s.d.; two-tailed unpaired t-test: ***P < 0.001; ****P < 0.0001.
Extended Data Fig. 2 | TERRA associates preferentially with short 
telomeres. a, TRF analysis of HeLa clones used for transient expression of 
TERRA. b, d, TERRA expression levels measured by RT–qPCR relative to the 
levels of TERRA in the clone with the shortest telomeres. n = 3 biologically 
independent experiments; data are means ± s.d. c, TRF analysis of HeLa clones 
expressing transgenic TERRA from the AAVS1 locus. e, HeLa clones of different 
telomere lengths were transiently transfected with the PP7–15qTERRA 
construct and co-localization was assessed by immunofluorescence with FISH 
(bottom). White arrows indicate co-localization of PP7 foci with the telomeric 
signal. The percentage of TERRA foci that co-localized with telomeres is 
plotted as a function of telomere length (top). Random colocalization events 
(roughly 3%) were not subtracted. f, Co-localization events as in e but for  
PP7–15qTERRA expressed from the AAVS locus on chromosome 19. n = 3 
biologically independent experiments; data are means ± s.d. Significant 
differences are indicated. Two-tailed unpaired t-tests were used to calculate 

















































































































































































































































































































































































Extended Data Fig. 3 | Depletion of factors regulating TERRA trafficking.  
a, Timeline of transfections and cell harvesting. mRNA levels were determined 
by RT–qPCR for long-telomere and short-telomere cell lines. b, For the second 
replicate of each siRNA screen, the level of depletion was also evaluated on 
western blots. Vinculin and hnRNPA1 were used as loading controls. c, Numbers 
of TERRA foci per cell are plotted for each depleted factor. n = 2 biologically 
independent experiments; at least 40 nuclei were analysed per condition.  
d, Quantification of endogenous TERRA stemming from the ends of 
chromosomes 15q, 13q and 10q upon depletion of the indicated factors  













































































































































































Extended Data Fig. 4 | Depletion of RAD51 and BRCA2, which regulate the 
association of TERRA with telomeres. a, HeLa clones with long and short 
telomeres were transfected with siRAD51 and siBRCA2, and then with chimaeric 
TERRA constructs. Representative immunoblots show RAD51 and BRCA2 
depletion, with vinculin as a loading control. Upon depletion, co-localization of 
TERRA with telomeres was assessed with immunofluorescence–FISH. n = 2 
biologically independent experiments; at least 54 nuclei were analysed per 
condition; data are means ± s.d. One-way ANOVA with Dunnett’s multiple 
comparisons test was used, comparing all conditions to siCONTROL: *P < 0.05; 
**P < 0.01; ***P < 0.001. b, Detection of endogenous and transgenic RAD51 on a 
western blot. Endogenous RAD51 was depleted with siRNA, and wild-type (WT) 













































































































Extended Data Fig. 5 | RNaseH1-regulated formation of telomeric R-loops 
in trans. a, RNH1 depletion and overexpression (OE) was assessed by western 
blotting in cell lines with long and short telomeres and upon TERRA 
overexpression. b, Representative example of one DRIP assay followed by qPCR 
for the end of chromosome 13q. Left, quantification of RNA–DNA hybrids is 
expressed as a fraction of input. Right, the amplified DNA was run on a gel, then 
isolated and sequenced.
Extended Data Fig. 6 | Transgenic TERRA expressed from plasmids induces 
telomere fragility. a, Representative examples of metaphase chromosomes 
stained with FISH to visualize telomeres. DNA is stained with DAPI. Fragile 
telomeres are indicated by white arrowheads. b, Quantification of telomere 
fragility. c, Quantification of telomere fragility in cells expressing PP7–
15qTERRA in which expression of RNaseH1 (RNH1) and RAD51 was manipulated 
as indicated. For b, c, the numbers of metaphases scored over three 
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Extended Data Fig. 7 | See next page for caption.
Extended Data Fig. 7 | RAD51 binds TERRA and promotes R-loop formation. 
a, Detection of endogenous telomeric R-loops on dot-blots as in Fig. 2a. Cells 
were transfected with siCONTROL (siC), siRNH1 or siRAD51. b, Possible models 
for the roles of RAD51 in mediating TERRA–telomere associations. Upper row, 
RAD51 binds telomeric single-stranded DNA, inducing strand invasion of 
another telomere. TERRA hybridizes to the displaced strand upon branch 
migration. Lower row, RAD51 binds TERRA directly and initiates homology 
search and strand invasion by TERRA at a telomere. c, Western blot analysis of 
RAD51 and hnRNPA1 upon immunoprecipitation (IP) of native RNA (see Fig. 3a 
for RNA analysis). SN, supernatant. d, Native Immunoprecipitation of RNA was 
performed in U2OS cell extracts, demonstrating the association of TERRA with 
RAD51 and hnRNPA1. n = 3 biologically independent experiments; data are 
means ± s.d. e, Affinity of RAD51 for TERRA and non-telomeric-RNA  
(Non-TelRNA) oligonucleotides. Quantification is shown on the right. n = 3 
independent experiments; data are means ± s.d. f, Top, stability EMSA assay. 
Bottom, 20 nM TERRA (lanes 2-7) or TelDNA (lanes 9-14) oligonucleotides were 
pre-bound with RAD51 (2.2 μM or 8.8 μM) and challenged with increasing 
concentrations of unlabelled competitor ssDNA (cDNA; 0.28 μM, 0.56 μM, 
1.13 μM, 2.27 μM or 4.54 μM). Quantification is shown on the right. n = 3 
independent experiments; data are means ± s.d.
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Extended Data Fig. 8 | See next page for caption.
Extended Data Fig. 8 | RAD51 catalyses the formation of canonical R-loops. 
a, Left, the RAD51 II3A mutant (lines 2–5; 325 nM, 650 nM, 1,300 nM or 
2,600 nM) or wild-type RAD51 (lines 6 and 7; 325 nM or 650 nM) was incubated 
with TERRA oligonucleotide substrate (50 nM), and then plasmid containing 
the homologous region was added. Right, quantification of R-loops in the 
presence of wild-type RAD51 or RAD51 II3A. n = 2 independent experiments; 
data are means ± s.d. b, Top, the R-loop and D-loop assays. After RAD51-
mediated R-loop or D-loop formation, proteins were digested with proteinase 
K (PK), which was then inactivated with PMSF and EGTA. Bottom left, R-loops or 
D-loops were detected on native gels as indicated. Treatment with RNaseH1, 
which degrades the RNA moiety in RNA–DNA hybrid structures, eliminates 
R-loops but has no effect on D-loops. RNaseH2, which cleaves ribonucleotides 
in DNA, has no effect, as expected. Right, quantification. n = 3 independent 
experiments; data are means ± s.d. c, Top, the R-loop and D-loop assays. Middle 
and bottom, RAD51-mediated R-loops (middle; n = 3 independent experiments; 
data are means ± s.d.), unlike D-loops (n=1 experiment), are recognized by the 
S9.6 antibody and supershifted in presence of both S9.6 and anti-mouse IgG. 
Quantification is shown on the right.
Article
Extended Data Table 1 | Oligonucleotides used herein
Extended Data Table 2 | Antibodies used herein
IF, immunofluorescence; IP, immunoprecipitation; WB, western blot.
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Microscopy images were acquired on an Upright Zeiss Axioplan or on a Zeiss LSM700 equipped with an AxioCam MRm B/W. The screens 
were developed on a Typhoon phosphorimager (GE). Western Blot membranes were developed on a Vilber Fusion FX imaging system. 
EMSA Gels were imaged on a FLA-9000 scanner (Fujifilm) and quantified with Multi Gauge V3.2 (Fujifilm). 
Data analysis Images were processed and analyzed with Image J (2.0.0-rc-69/1.52n). Graphs were prepared in GraphPad Prism 7 (7.0d) and Figures 
assembled using Adobe Photoshop (21.1.0) and Adobe Illustrator (24.0.3).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
All materials and data-sets are available upon request. 
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Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No statistical method was used to pre-determine sample size. Sample sizes were chosen according to commonly used standards in the field. 
(Azzalin et al. Science. 2007 Nov 2;318(5851):798-801; Vančevska et al. EMBO J. 2020 Apr 1;39(7):e102668) The number of independent 
experiments are indicated in the legend of each Figure. Proper Negative and whenever possible positive controls were used for each 
experiment.
Data exclusions No data was excluded from the analysis
Replication The screen in Figure 2c was performed in two independent biological replicates. All the other experiments were performed in three 
independent biological replicates. All the replicates were successful
Randomization All samples were chosen randomly
Blinding For Figures 1c, 1d, 2c, 2d, and Ext. Figure 2e, 2f, 4a the researchers were blinded to image acquiring and analysis. For the rest either the 
differences between samples were obvious making blinding impossible or blinding was not applicable due to the nature of the experiment.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems













Antibodies used See also Table S2: 
GFP Home-Made   
GFP Merck Millipore MAB3580 
RAD51 Santa-Cruz sc-8349 
RAD51 ABCAM ab133534 
BRCA2 Merck Millipore MAB3580 
Vinculin ABCAM ab129002 
hnRNPA1 Santa-Cruz sc-32301 
RNaseH1 GeneTex GTX-117624 
TRF1 Santa-Cruz sc-6165R 
TRF2 Merck Millipore 05-521 
POT1 ABCAM ab124784 
SMG1 Abgent AP8055a 
UPF1 Bethul Laboratories A300-037A 
RPA2 ABCAM ab2175 
Anti-DNA-RNA Hybrid [S9.6] Kerafast ENH001 
Anti-Rabbit IgG (H+L), HRP conjugate, Promega, W4011 
Anti-Mouse IgG (H+L), HRP conjugate, Promega, W4021 
Goat Anti-Rabbit IgG (H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 633, ThermoFisher, A-21070
Validation Validation for each antibody is provided in the manuscript. The specificity of most of them (including the home-made GFP 
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antibody) was tested upon disappearance of the corresponding band upon siRNA knock down in this study. S9.6 specificity for 
DNA-RNA hybrids is confirmed by in-vitro treatment with RNAseH1. 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) HeLa and HEK293T cell lines were purchased from ATCC. U2OS was purchased from ECACC
Authentication HeLa and HEK293Tcell lines have not been authenticated by us but the supplier. U2OS cell line was authenticated by 
measuring the production of c-circles (a known ALT cell line phenotype)
Mycoplasma contamination All the cell lines were tested negative for mycoplasma
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used
